TRACON Pharmaceuticals Inc (TCON)
1.79
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Revenue (Quarterly): 3.045M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.045M |
| September 30, 2023 | |
| June 30, 2023 | 9.00M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 0.346M |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 3.00M |
| December 31, 2017 | |
| September 30, 2017 | 7.498M |
| June 30, 2017 | 0.631M |
| March 31, 2017 | 0.626M |
| December 31, 2016 | 0.617M |
| September 30, 2016 | 0.815M |
| June 30, 2016 | 0.807M |
| March 31, 2016 | 1.21M |
| December 31, 2015 | 1.395M |
| September 30, 2015 | 1.18M |
| June 30, 2015 | 4.197M |
| March 31, 2015 | 1.132M |
| December 31, 2014 | 1.04M |
| September 30, 2014 | 1.133M |
| June 30, 2014 | 1.069M |
| March 31, 2014 | 0.356M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.346M
Minimum
Jun 2021
9.00M
Maximum
Jun 2023
4.130M
Average
3.045M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
| BioSig Technologies Inc | 0.012M |
| Revolution Medicines Inc | 0.742M |
| Perspective Therapeutics Inc | -5.239M |
| Electromed Inc | 13.69M |
| Xtant Medical Holdings Inc | 28.11M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.439M |
| Total Expenses (Quarterly) | 0.263M |
| EPS Diluted (Quarterly) | 0.40 |
| Enterprise Value | -4.491M |
| Profit Margin (Quarterly) | 14.42% |
| Earnings Yield | -279.3% |
| Normalized Earnings Yield | -327.23 |